Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bwahajaa! Goose the stock and stick the newbs.. dump.. wash/dry/repeat!
Its indicative of how soon it will take the diluters to overcome the dreamers..
Well shucks, time for a Hampster Dance - Lol! http://www.angelfire.com/ak2/intelligencerreport/page50.index.html
RXMD.. King of the Pump & Dumps!
How is everyone here at Progressive Dilution?
Progressive Care = Progressive DILUTION..
RXMD Voted Most Boring Stock by StockTwits..
RXMD BK VALUE = 202,473/341,107,607 = $0.0006
Shareholder Equity 06/30/2016: $202,473
Divide that by o/s Shares: 341,107,607
No, it wasn't Retail Dumping.. RXMD DILUTION!
I'm not, but Dilution Kills every attempt..
So Much for Restricted Shares..
On April 6, 2016 RXMD entered into an agreement with Midam Ventures for marketing services totaling $90,000 payable half in monthly cash payments and half ($45,000) in RESTRICTED shares.
On April 6, 2016 RXMD entered into an agreement with Mass Ventures for web development services totaling $50,000 payable in monthly cash payments totaling $15,000 and the balance ($35,000) payable in RESTRICTED shares, half up-front and the remaining shares on completion.
Per RXMD Form 10-Q thru Jun-2016, page 18 states that 1,125,000 RESTRICTED shares were issued to Midam Ventures and 437,500 RESTRICTED shares were issued to Mass Ventures on May 27, 2016.
THIS PROVES RXMD RESTRICTED SHARES WERE ONLY RESTRICTED FROM APR-2016 TO DATE OF ISSUANCE MAY-2016, DISPROVING SHAREHOLDER PERCEPTION THAT RXMD RESTRICTED SHARES COULD NOT BE ISSUED FOR A TERM OF ONE YEAR..
Wonder how soon Chicago Ventures can sell those ~75 MILLION converted shares totaling $2,205,000? THEY ALREADY CAN BECAUSE THE RESTRICTION IS NOT 1 YEAR, ITS 1 MONTH!!!
Lots of 100K Dumps today!
RED Again.. and a whole new batch of Baggers!
Well that was interesting.. More Marks on-board for the Diluters to cash out higher. RXMD King of the Diluters!
That $2.98 purchase is NOT retail!
Painting isn't for Longs Benefit, for Share Dilution!
Yep, 100 shs Painted at .0298 LOL! ($2.98) 15:59:54
Watch for Another Painted Close!
RXMD is another Name for DILUTION..
RED Again... Bwahajaaa! Who da thunk?
Consistent paint job closings proves the scam RXMD is..
150K short each trade due to lack of liquidity..
I shorted this twice over a nickel and posted my trades, still short on 2nd one..
Every contract is a convertible share scam with P&D news.. I've shorted this twice and made bank each time.
Cheat way to pump their Rev #s, but govt revs don't cover their cost..
There's 1000 EPEP Pharmacies, not a Big Deal..
http://www.phe.gov/Preparedness/planning/national-plus/Pages/NationalPlus.aspx
For the Mark who looks around the room searching for who's It..
Link to RXMD T/A..
Bearish on all time frames w/Very Bearish Candlestick -
http://www.stockta.com/cgi-bin/analysis.pl?symb=RXMD&cobrand=&mode=stock
RXMD Death Cross..50MA Close to Crossing Down thru 200MA
It is, and with unaudited financials who knows why shareholders end up paying all the company bills thru stock sale dilution. Every scheme they come up with costs shareholders in shares..
History of RXMD Dilution Machine..
History of RXMD Dilution thru Jun-2016..
Issued to Original S/H………………………2,280,000…… 2007
Issued for Debt………………………………3,000,000……2008-2009
Issued for PharmCo Acquisition………….30,000,000……2010-2010
Issued for Services……………………….……302,261……2010-2011
Issued for Services-Armen…………….……1,385,596……2010-2011
Issued for Debt………………………….……1,098,973……2010-2011
Restated Original S/H Issue………….……-1,718,000……2010-2011
Issued for Debt………………………….……..196,078……2011-2012
Issued for Services…………………….……….60,000……2011-2012
Issued for Services-Armen………….………..424,983……2011-2012
Retired PharmCo Issue……………….….-12,208,432……2011-2012
Issued for Debt………………………………2,500,000……2012-2013
Issued for Services……………………….……234,885……2012-2013
Issued for Services-Armen…………………...150,000……2012-2013
Issued for Services-Armen…………………5,000,000……2013-2014
Issued for Debt-3(a)(10) ……………………8,362,000……2013-2014
Issued for Debt-3(a)(10)…………………273,913,000……2014-2015
Issued for Services………………………...20,000,000……2014-2015
Issued for Debt………………………………6,083,985……2014-2015
Issued for Bonuses………………………..10,977,716……2014-2015
Retired Debt Issuance-3(a)(10)…………-12,497,838……2015-2016
Issued for Services………………………….1,562,500……May-2016
Total……………………………………….341,107,607
Issued Share Summary thru Jun-2016:
Issued to Original S/H…………………………562,000
Issued for PharmCo Acquisition………….17,791,568
Issued for Services-Armen…………………6,960,579
Issued for Other Services…………………22,159,646
Issued for Bonuses…………………….…..10,977,716
Issued for Debt…………………………...282,656,198
Total…………………………………….…341,107,607
Subsequent Contracts/Remaining Dilution Since Jun-2016..
08/22/2016: MBS Due Diligence Fee-Fully Vested Shs….500,000
02/22/2017: MBS Due Diligence Fee-Balance Shs..........500,000
04/06/2016: Mass Ventures.....Remaining Shs valued at......$ 17,500
07/22/2016: Chicago Ventures...Remaining Shs valued at...$2,205,000
Since RXMD only has 500M shares authorized, expect to see this increased then followed by a reverse split of the corporate shares..
500,000 shs were paid to MBS as fully vested 08/22/2016 as a Due Diligence Fee along with $10,000 paid in cash. Another 500,000 shs will be payable to MBS payable in 6 months.
Upon successful financing, MBS gets another 11% in stock/cash. Upon successful M&A, MBS gets another 15% in stock/cash.
MBS will facilitate RXMD in obtaining convertible debt or mezzanine financing along with warrants..
http://www.otcmarkets.com/otciq/ajax/showNewsReleaseDocumentById.pdf?id=21849
Its no buyout, just a more expensive Toxic convertible financing deal..
Half the shares (500,000) were paid on signing along with $10K cash.. Just read the contract with MBS..
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124705668
Every Deal RXMD Does Costs You in Shares..
Typical of a Stinky Pinky people!
RXMD Paying an Expensive Middle Man for Another Loan..
In stock of course, as will the "financing" be. So on top of getting more funds paid for in stock, they now have to revert to paying both a middle man fees for the loan on top of loan fees from a lender. The term "M&A" was just put into the wording to make you think anyone would buy RXMD, because its worth zero after all the shares have been pledged for cash, your cash!
ACTUAL CONTRACT SIGNED WITH MBS..
The Company agrees to pay MBS fees upon the successful completion of a Financing or an M&A Transaction as follows: Due Diligence Fee. (i) $10,000 cash fee will be paid to MBS upon the execution of this Agreement, and (ii) 1,000,000 shares of the Company’s Common Stock pursuant to a restricted stock grant to MBS, of which 500,000 shares will vest immediately, and 500,000 shares will vest 180 days from the Effective Date.
For each Financing, the Success Fee will be (a) a cash fee equal to 8% of the gross proceeds from any equity Financing, 8% of the gross proceeds from any convertible debt or mezzanine Financing, and 3% of the gross proceeds from any debt Financing and in all instances including, without limitation, upon exercise of any cash based warrants issued in any Financing, and (b) shares of the Company’s Common Stock (the “MBS Stock”) equal to 3% of the aggregate number of the fully diluted and/or converted shares of common stock and/or common stock equivalents purchased by the Investors (after giving effect to any warrants issued to the Investors in any Financing and the increase in shares under a ratchet or similar provision pursuant to which the number of shares initially acquired is subsequently increased) on the same terms and conditions as the Investors were granted. MBS may elect at its sole discretion to receive its Success Fee in stock at a higher rate than presented above, such that the combination of cash and stock may not exceed 11% and the cash portion may not exceed 8% of the gross proceeds from any financing facilitated by MBS.
The cash portion of the Success Fee will be due and payable upon the closing of each Financing and will be payable directly to MBS from the escrow established for such closing or in such other manner as may be acceptable to MBS. Immediately prior to closing of a Financing, the Company will sign a payment authorization letter, in a form to be prepared at the sole discretion of MBS, irrevocably instructing the Financing source or Escrow Agent to deduct the Success Fees due to MBS from the Financing and remit those Success Fees directly to MBS.
The shares of the Company’s Common Stock to be issued to MBS will carry piggy-back registration rights. The Company warrants that the Shares to be issued to MBS under this Agreement will be validly issued, fully paid and non-assessable and that the Company’s Board of Directors has or shall have duly authorized the issuance and transfer of said Shares to MBS.
For each M&A Transaction, the Success Fee will be a fee in the same form of consideration paid or received by the Company equal to the following schedule of the Total Consideration (as defined below) with respect to such M&A Transaction:
5% of the first $5,000,000 of Total Consideration, or any part; plus,
4% of the second $5,000,000 of Total Consideration, or any part; plus,
3% of the third $5,000,000 of Total Consideration, or any part; plus,
2% of the next $5,000,000 of Total Consideration, or any part; plus,
1% of the balance of the Total Consideration
RXMD $2,205,000 floorless convertible is TOXIC because its convertible at the LOWER of Market or a nickel. The ceiling is a nickel and the floor price can go to ZERO!
Mass Ventures, the web development consultant doesn't even have a website of its own. And why wouldn't RXMD just contract Midam for web & marketing? Midam does both. My suspicion is they are taking the funds earmarked for Mass Ventures personally on a split, since both Armen and the CEO of Mass Ventures were college room-mates. Something for longs to consider given Armen's past securities fraud with FINRA..